Literature DB >> 25332240

Extracellular signal-regulated kinase signaling regulates the opposing roles of JUN family transcription factors at ETS/AP-1 sites and in cell migration.

Nagarathinam Selvaraj1, Justin A Budka1, Mary W Ferris1, Joshua P Plotnik2, Peter C Hollenhorst3.   

Abstract

JUN transcription factors bind DNA as part of the AP-1 complex, regulate many cellular processes, and play a key role in oncogenesis. The three JUN proteins (c-JUN, JUNB, and JUND) can have both redundant and unique functions depending on the biological phenotype and cell type assayed. Mechanisms that allow this dynamic switching between overlapping and distinct functions are unclear. Here we demonstrate that JUND has a role in prostate cell migration that is the opposite of c-JUN's and JUNB's. RNA sequencing reveals that opposing regulation by c-JUN and JUND defines a subset of AP-1 target genes with cell migration roles. cis-regulatory elements for only this subset of targets were enriched for ETS factor binding, indicating a specificity mechanism. Interestingly, the function of c-JUN and JUND in prostate cell migration switched when we compared cells with an inactive versus an active RAS/extracellular signal-regulated kinase (ERK) signaling pathway. We show that this switch is due to phosphorylation and activation of JUND by ERK. Thus, the ETS/AP-1 sequence defines a unique gene expression program regulated by the relative levels of JUN proteins and RAS/ERK signaling. This work provides a rationale for how transcription factors can have distinct roles depending on the signaling status and the biological function in question.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25332240      PMCID: PMC4295391          DOI: 10.1128/MCB.00982-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

Review 1.  The mammalian Jun proteins: redundancy and specificity.

Authors:  F Mechta-Grigoriou; D Gerald; M Yaniv
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

2.  Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP.

Authors:  Mary L Nelson; Hyun-Seo Kang; Gregory M Lee; Adam G Blaszczak; Desmond K W Lau; Lawrence P McIntosh; Barbara J Graves
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-13       Impact factor: 11.205

3.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

4.  Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.

Authors:  Peter C Hollenhorst; Mary W Ferris; Megan A Hull; Heejoon Chae; Sun Kim; Barbara J Graves
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

5.  Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

Authors:  C M Pfarr; F Mechta; G Spyrou; D Lallemand; S Carillo; M Yaniv
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

6.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

Review 7.  At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone.

Authors:  John Foley; Nicole Nickerson; David J Riese; Peter C Hollenhorst; Gwendolen Lorch; Anne M Foley
Journal:  Odontology       Date:  2012-06-10       Impact factor: 2.634

8.  Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.

Authors:  Charles E Foulds; Mary L Nelson; Adam G Blaszczak; Barbara J Graves
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.

Authors:  R Gum; E Lengyel; J Juarez; J H Chen; H Sato; M Seiki; D Boyd
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

10.  AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKL.

Authors:  M J Stankiewicz; J D Crispino
Journal:  Leukemia       Date:  2013-02-05       Impact factor: 11.528

View more
  13 in total

1.  JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor-β (TGF-β)-induced Inhibition of Cell Proliferation.

Authors:  Ana Cecilia Millena; BaoHan T Vo; Shafiq A Khan
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

2.  Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.

Authors:  Bethtrice Elliott; Ana Cecilia Millena; Lilya Matyunina; Mengnan Zhang; Jin Zou; Guangdi Wang; Qiang Zhang; Nathan Bowen; Vanessa Eaton; Gabrielle Webb; Shadyra Thompson; John McDonald; Shafiq Khan
Journal:  Cancer Lett       Date:  2019-02-11       Impact factor: 8.679

3.  c-Jun enhances intestinal epithelial restitution after wounding by increasing phospholipase C-γ1 transcription.

Authors:  Peng-Yuan Wang; Shelley R Wang; Lan Xiao; Jie Chen; Jian-Ying Wang; Jaladanki N Rao
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-18       Impact factor: 4.249

4.  Aberrant expression of ETS1 and ETS2 proteins in cancer.

Authors:  Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Rep Rev       Date:  2018-04-23

5.  Transcriptome profiling of 3D co-cultured cardiomyocytes and endothelial cells under oxidative stress using a photocrosslinkable hydrogel system.

Authors:  Xiaoshan Yue; Aylin Acun; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2017-06-23       Impact factor: 8.947

6.  Catestatin reverses the hypertrophic effects of norepinephrine in H9c2 cardiac myoblasts by modulating the adrenergic signaling.

Authors:  Md Jahangir Alam; Richa Gupta; Nitish R Mahapatra; Shyamal K Goswami
Journal:  Mol Cell Biochem       Date:  2019-12-02       Impact factor: 3.396

7.  Gene Network Dysregulation in Dorsolateral Prefrontal Cortex Neurons of Humans with Cocaine Use Disorder.

Authors:  Efrain A Ribeiro; Joseph R Scarpa; Susanna P Garamszegi; Andrew Kasarskis; Deborah C Mash; Eric J Nestler
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

8.  Transregulation of microRNA miR-21 promoter by AP-1 transcription factor in cervical cancer cells.

Authors:  Sacnite Del Mar Díaz-González; Eduardo Daniel Rodríguez-Aguilar; Angélica Meneses-Acosta; Viviana Valadez-Graham; Jessica Deas; Claudia Gómez-Cerón; Carlos Alberto Tavira-Montalván; Alitzel Arizmendi-Heras; Julián Ramírez-Bello; Mario Enrique Zurita-Ortega; Berenice Illades-Aguiar; Marco Antonio Leyva-Vázquez; Gloria Fernández-Tilapa; Víctor Hugo Bermúdez-Morales; Vicente Madrid-Marina; Mauricio Rodríguez-Dorantes; Carlos Pérez-Plasencia; Oscar Peralta-Zaragoza
Journal:  Cancer Cell Int       Date:  2019-08-15       Impact factor: 5.722

9.  Fra-1 regulates its target genes via binding to remote enhancers without exerting major control on chromatin architecture in triple negative breast cancers.

Authors:  Fabienne Bejjani; Claire Tolza; Mathias Boulanger; Damien Downes; Raphaël Romero; Muhammad Ahmad Maqbool; Amal Zine El Aabidine; Jean-Christophe Andrau; Sophie Lebre; Laurent Brehelin; Hughes Parrinello; Marine Rohmer; Tony Kaoma; Laurent Vallar; Jim R Hughes; Kazem Zibara; Charles-Henri Lecellier; Marc Piechaczyk; Isabelle Jariel-Encontre
Journal:  Nucleic Acids Res       Date:  2021-03-18       Impact factor: 16.971

10.  ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor.

Authors:  Shan Zeng; Adrian M Seifert; Jennifer Q Zhang; Teresa S Kim; Timothy G Bowler; Michael J Cavnar; Benjamin D Medina; Gerardo A Vitiello; Ferdinand Rossi; Jennifer K Loo; Nesteene J Param; Ronald P DeMatteo
Journal:  Oncotarget       Date:  2017-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.